Acerus Pharmaceuticals (TSX:ASP) Purchase Of Investment : C$0.00 Mil (TTM As of Sep. 2022)

View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Purchase Of Investment?

Acerus Pharmaceuticals's purchase of investment for the three months ended in Sep. 2022 was C$0.00 Mil. It means Acerus Pharmaceuticals spent C$0.00 Mil on purchasing investments. Acerus Pharmaceuticals's purchase of investment for the trailing twelve months (TTM) ended in Sep. 2022 was C$0.00 Mil.

Compared with last quarter (C$0.00 Mil in Jun. 2022 ), Acerus Pharmaceuticals spent the same money on purchasing investments in Sep. 2022 (C$0.00 Mil).

Acerus Pharmaceuticals Purchase Of Investment Historical Data

The historical data trend for Acerus Pharmaceuticals's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals Purchase Of Investment Chart

Acerus Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Purchase Of Investment

Get a 7-Day Free Trial

Acerus Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Purchase Of Investment	Get a 7-Day Free Trial															-	-	-	-	-

Acerus Pharmaceuticals Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

Acerus Pharmaceuticals Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Acerus Pharmaceuticals's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Acerus Pharmaceuticals (TSX:ASP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Purchase Of Investment

Comparable Companies

Traded in Other Exchanges

N/A

Address

7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8

Website

https://www.aceruspharma.com

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Executives

Norma Beauchamp	Director
Stephen Robert Gregory	Director
Edward Joseph Gudaitis	Director, Senior Officer